Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) - Total Assets
Based on the latest financial reports, Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) holds total assets worth ILA7.83 Million ILA (≈ $21.01K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Tikun Olam Cannbit Pharmaceuticals Ltd - Total Assets Trend (2017–2024)
This chart illustrates how Tikun Olam Cannbit Pharmaceuticals Ltd's total assets have evolved over time, based on quarterly financial data. Also see Tikun Olam Cannbit Pharmaceuticals Ltd stock valuation for the company's overall valuation and market capitalisation.
Tikun Olam Cannbit Pharmaceuticals Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Tikun Olam Cannbit Pharmaceuticals Ltd's total assets of ILA7.83 Million consist of 27.0% current assets and 73.0% non-current assets. Review Tikun Olam Cannbit Pharmaceuticals Ltd balance sheet liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0.7% |
| Accounts Receivable | ILA3.92 Million | 16.3% |
| Inventory | ILA1.26 Million | 5.3% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA9.81 Million | 40.9% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Tikun Olam Cannbit Pharmaceuticals Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tikun Olam Cannbit Pharmaceuticals Ltd's current assets represent 27.0% of total assets in 2024, a decrease from 704.2% in 2017.
- Cash Position: Cash and equivalents constituted 0.7% of total assets in 2024, down from 51.7% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 40.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is intangible assets at 40.9% of total assets.
Tikun Olam Cannbit Pharmaceuticals Ltd Competitors by Total Assets
Key competitors of Tikun Olam Cannbit Pharmaceuticals Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM
|
India | Rs443.12 Billion |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Beijing Tongrentang Co Ltd
SHG:600085
|
China | CN¥29.95 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
|
Harbin Pharmaceutical Group Co Ltd
SHG:600664
|
China | CN¥14.08 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
Tikun Olam Cannbit Pharmaceuticals Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.20 | 0.60 | 2.54 |
| Quick Ratio | 0.17 | 0.48 | 1.98 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA-16.35 Million | ILA-10.33 Million | ILA28.01 Million |
Tikun Olam Cannbit Pharmaceuticals Ltd - Advanced Valuation Insights
This section examines the relationship between Tikun Olam Cannbit Pharmaceuticals Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 12.63 |
| Latest Market Cap to Assets Ratio | 1.17 |
| Asset Growth Rate (YoY) | -68.6% |
| Total Assets | ILA24.01 Million |
| Market Capitalization | $28.21 Million USD |
Valuation Analysis
Above Book Valuation: The market values Tikun Olam Cannbit Pharmaceuticals Ltd's assets above their book value (1.17x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Tikun Olam Cannbit Pharmaceuticals Ltd's assets decreased by 68.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Tikun Olam Cannbit Pharmaceuticals Ltd (2017–2024)
The table below shows the annual total assets of Tikun Olam Cannbit Pharmaceuticals Ltd from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ILA24.01 Million ≈ $64.36K |
-68.65% |
| 2023-12-31 | ILA76.57 Million ≈ $205.29K |
-51.17% |
| 2022-12-31 | ILA156.82 Million ≈ $420.44K |
-17.36% |
| 2021-12-31 | ILA189.78 Million ≈ $508.79K |
-2.58% |
| 2020-12-31 | ILA194.81 Million ≈ $522.29K |
+25.34% |
| 2019-12-31 | ILA155.43 Million ≈ $416.69K |
+2084.16% |
| 2018-12-31 | ILA7.12 Million ≈ $19.08K |
+5930.51% |
| 2017-12-31 | ILA118.00K ≈ $316.35 |
-- |
About Tikun Olam Cannbit Pharmaceuticals Ltd
Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers training and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd … Read more